{
  "hadm_id": "21416766",
  "note_id": "11287183-DS-22",
  "note": " \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \n___\n \nAttending: ___\n \nChief Complaint:\nAbdominal Pain \n \nMajor Surgical or Invasive Procedure:\nPercutaneous cholecystostomy ___\n\n \nHistory of Present Illness:\n___ male with borderline resectable pancreatic cancer stage\nIIB (T3 N1 M0) s/p 5 cycles of neoadjuvant FOLFIRINOX, 30Gy\nexternal beam radiation, and distal pancreatectomy with ypT0N0\n(___), complicated by pancreatic leak, GIB, PE and\npolymicrobial infections, s/p transgastric biopsy on ___\nshowing recurrent adenocarcinoma, presenting from clininc with\nsevere abdominal pain found to have acute cholecystitis\n\nHe states he was ___ his usual state of health until a few days\nago . He was ___ ___ for Stand up to cancer event when he began to\nhave increasing RUQ pain. He also noted some nausea. He flew \nback\nhome yesterday and began to have dry heaves. He denies any \nfevers\nor sick contacts. He went to see his outpatient team who noted a\npositive ___ sign on exam. They sent him for urgent RUQUS\nwhich was read as \"gallbladder wall is  irregular with some \nfocal\nedema.  The appearance is worrisome for cholecystitis.\" He was\ngiven cipro and flagyl. Labs were sent which were remarkable for\nelevated WBC 23.3, normal LFTs. He was subsequently directly\nadmitted to medicine floor. \n\nOn arrival to the floor he is having ___ RUQ pain. He denies \nany\nother symptoms.\n\n \nPast Medical History:\nPAST ONCOLOGIC HISTORY (Per OMR, reviewed):\nPancreatic cancer stage IIB (T3N1M0)\n- ___ CT urogram for history of kidney stones showed\nnormal kidneys bilaterally w/o any stones. Incidentally, was\nnoted to have a 4.5 x 4.4 x 5cm enhancing mass along the lesser\ncurvature ofhte stomach, extending inferiorly \ninto the pancreatic tail. From the study, unclear if mass was\narising from the stomach or pancreas. \n- ___ EGD revealed a possible submucosal mass on the\ngastric side of the  GE junction ___ the cardia, which was\nbiopsied and normal. Although HP immunostains were negative, he\nwas started on Prevpac for possible HP infection. GI recommended\ndedicated CTAP. \n- ___ CT abdomen and pelvis demonstrated a 5 x 5 x 4.6 cm\nmass contiguous with the superior aspect of the proximal\npancreatic tail causing extrinsic compression on the lesser\ncurvature of the stomach. \n- ___ EUS showed a 4.7 x 3.2 cm pancreatic tail mass \nwhich\ndid invade the muscular propria of the gastric wall. Although\ndifferential for GIST or NET, FNA/B c/w poorly differentiated\nadenosquamous carcinoma (positive for \ncytokeratin AE1/3 CAM5.2 and focally positive for p40, p63 and\nmucicarmine  stains. Synaptophysin, chromogranin, and CDX2\nimmunostains are negative)\n- ___ CT torso showed an extensive tumor involving the\npancreatic body/tail and extending to the gastric wall to the\nleft adrenal gland. CT chest notable for a subcarcinal lesion\nconcerning for a nodal conglomerate versus unrelated lesion. \n- ___ C1D1 FOLFIRINOX\n- ___ C1D15 FOLFIRINOX (no bolus ___, Iri 150 mg/m2)\ndelayed for low PLT and diarrhea. \n- ___ Biopsy of the paraesophageal lesion showed no\nmetastatic disease but nondiagnostic\n- ___ Start isoquercetin 1000 mg PO daily on ___\n- ___ C2D1 FOLFIRINOX (no bolus ___, Iri 150 mg/m2)\n- ___ CTA torso showed substantial reduction ___ disease\nburden\n- ___ C3D1 FOLFIRINOX (no bolus ___ 1800 mg/m2, Iri\n135 mg/m2) dose reduced for mild mucositis and diarrhea\n- ___ ___ FOLFIRINOX (no bolus ___ 1800 mg/m2, Iri\n135 mg/m2) delayed for patient vacation\n- ___ C4D1 FOLFIRINOX (no bolus ___ 1800 mg/m2, Iri\n135 mg/m2)\n- ___ Held chemo for toxicity\n- ___ CTA torso showed further reduction ___ disease \nburden\n- ___ C4D15 dose of FOLFIRINOX (no bolus ___ 1800\nmg/m2, Iri 100 mg/m2) reduced for fatigue and diarrhea\n- ___ C5D1 FOLFOX (no bolus ___ 1800 mg/m2, Iri on\nhold) for fatigue and diarrhea\n- ___ Start chemoXRT with sensitizing capecitabine\n- ___ Complete chemoXRT with 30 Gy to the tumor bed and\nmargins\n- ___ Underwent distal pancreatectomy and splenectomy \nwith\nintraoperative XRT of 10 Gy to the margin. Pathology showed a\nypT0N0 complete response with 22 LNs assessed. \n\nPAST MEDICAL HISTORY:\n- Status post total knee replacement on the left.\n- Status post rotator cuff surgery.\n- Status post kidney stones.\n- He has a plate ___ his jaw from a broken jaw.\n- Diabetes.\n- Hyperlipidemia.\n- Pulmonary embolism ___ ___ admission)\n\n \nSocial History:\n___\nFamily History:\nMother with COPD.\nFather died of old age at age ___.\nNo family history of malignancy.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nVS:  ___ Temp: 100.9 PO BP: 117/64 HR: 85 RR: 18 O2\nsat: 95% O2 delivery: Ra \nGeneral Appearance: ill appearing laying ___ bed \nEyes: PERLL, EOMI, no conjuctival injection, anicteric\nRespiratory: CTA b/l with good air movement throughout\nCardiovascular: RR, S1 and S2 wnl, no murmurs, rubs or gallops\nGastrointestinal: nd, +b/s, ___ sign, no rebound or\nguarding \nExtremities: no cyanosis, clubbing or edema\nSkin: warm, no rashes/no jaundice/no skin ulcerations noted\nNeurological: Alert, oriented to self, time, date, reason for\nhospitalization\n\nDISCHARGE PHYSICAL EXAM:\n========================\nVITALS: ___ 0031 Temp: 98.3 PO BP: 104/72 HR: 80 RR: 20 O2\nsat: 98% O2 delivery: ra \nGen - sitting up ___ bed comfortably, NAD\nHEENT - NC/AT, MMM\nEyes - anicteric sclerae, PERRLA\n___ - RRR, no murmurs\nPulm - CTAB, no wheezes or crackles\nGI - soft, mild discomfort to palpation ___ RUQ, non distended,\n+bowel sounds, no guarding, + perc chole tube draining clear\nyellow fluid\nExt - no edema\nSkin - warm and well perfused, no rashes\nNeuro - A&Ox3, fluent speech, moves all four extremities with\npurpose \n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 08:30AM BLOOD WBC-23.3* RBC-3.10* Hgb-10.2* Hct-29.6* \nMCV-96 MCH-32.9* MCHC-34.5 RDW-20.0* RDWSD-67.9* Plt ___\n___ 08:30AM BLOOD Neuts-78.4* Lymphs-3.8* Monos-15.9* \nEos-0.0* Baso-0.2 NRBC-0.2* Im ___ AbsNeut-18.27* \nAbsLymp-0.88* AbsMono-3.71* AbsEos-0.01* AbsBaso-0.04\n___ 08:30AM BLOOD Hypochr-NORMAL Anisocy-2+* Poiklo-1+* \nMacrocy-NORMAL Microcy-NORMAL Polychr-1+* Ovalocy-1+* \nSchisto-OCCASIONAL Burr-1+* Tear ___ \nPappenh-OCCASIONAL Bite-1+* Acantho-OCCASIONAL \nEllipto-OCCASIONAL\n___ 08:30AM BLOOD UreaN-8 Creat-0.7 Na-138 K-3.5 Cl-101 \nHCO3-22 AnGap-15\n___ 08:30AM BLOOD ALT-10 AST-15 LD(___)-161 AlkPhos-115 \nTotBili-0.8 DirBili-<0.2 IndBili-0.8\n___ 08:30AM BLOOD Albumin-2.6* Calcium-7.7* Phos-2.7 \nMg-1.5* UricAcd-6.0\n\nDISCHARGE LABS:\n===============\n___ 05:03AM BLOOD WBC-8.3 RBC-2.46* Hgb-8.1* Hct-24.0* \nMCV-98 MCH-32.9* MCHC-33.8 RDW-19.9* RDWSD-69.0* Plt ___\n___ 05:03AM BLOOD Glucose-100 UreaN-7 Creat-0.5 Na-140 \nK-4.0 Cl-106 HCO3-26 AnGap-8*\n___ 05:03AM BLOOD ALT-7 AST-14 LD(LDH)-115 AlkPhos-90 \nTotBili-0.3\n___ 05:03AM BLOOD Albumin-1.9* Calcium-7.0* Phos-2.9 Mg-1.8\n\nMICROBIOLOGY:\n=============\n___ 3:52 pm ABSCESS      Source: gallbladder. \n\n   GRAM STAIN (Final ___: \n      3+  ___ per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      2+   ___ per 1000X FIELD):   GRAM POSITIVE COCCI. \n                                    ___ PAIRS AND SINGLY. \n\n   FLUID CULTURE (Preliminary): \n      GRAM POSITIVE COCCUS(COCCI).    SPARSE GROWTH. \n      MIXED BACTERIAL FLORA. \n         This culture contains mixed bacterial types (>=3) so an\n         abbreviated workup is performed. Any growth of \nP.aeruginosa,\n         S.aureus and beta hemolytic streptococci will be \nreported. IF\n         THESE BACTERIA ARE NOT REPORTED, THEY ARE NOT PRESENT \n___ this\n         culture. \n         Work-up of organism(s) listed discontinued (except \nscreened\n         organisms) due to the presence of mixed bacterial flora \ndetected\n         after further incubation. \n\n   ANAEROBIC CULTURE (Preliminary):    NO ANAEROBES ISOLATED. \n\nIMAGING:\n===========\n___ LIVER OR GALLBLADDER US (SINGLE ORGAN)\nCholelithiasis and sludge ___ the gallbladder.  The gallbladder \nwall is\nirregular with some focal edema.  The appearance is worrisome \nfor\ncholecystitis.\n\n___ DRAINAGE,INTRO PERC TRANHEP BIL US\nSuccessful ultrasound-guided placement of ___ pigtail \ncatheter into the gallbladder. Samples were sent for \nmicrobiology evaluation.\n \nBrief Hospital Course:\n___ male with borderline resectable pancreatic cancer \nstage IIB (T3 N1 M0), s/p 5 cycles of neoadjuvant FOLFIRINOX \n(dose reduced and iri held given toxicity), s/p 30Gy SBRT with \ncapecitabine at ___, now s/p distal pancreatectomy and \nsplenectomy with intraoperative XRT of 10 Gy to the margin, with \nypT0N0, complicated by pancreatic leak, GIB, PE and \npolymicrobial infections, with biopsy proven recurrence at the \ngastric fundus\ns/p three doses of FOLFIRI, who presented with cholecystitis, \ns/p perc chole tube on ___ with relief of symptoms and \ndowntrending WBC count. He was kept on unasyn and discharged on \naugmentin to complete a ___holecystitis\nWith low grade temp and leukocytosis and evidence of \ncholecystitis on US. Surgery evaluated patient and favored ___ \nguided perc chole (___) which patient tolerated well. His \napixaban was restarted without incident the morning after the \nprocedure. He was kept on Unasyn and transitioned to augmentin \nfor 7day course (___) set to end ___.\n- Surgery following: to f/u with Dr. ___ ___ ___ weeks after \ndischarge\n\n# Pancreatic cancer, treating with curative intent.\n# Hx Upper GI Bleed: continued on BID pantoprazole\n# Pulmonary embolism: apixaban held for perc chole, per ___ \nrestarted AM ___.\n# L1 compression fracture: Followed by ___ spine\n\n#Code Status: Full Code\n#CONTACT: ___, wife, ___ (HCP)\n\nTransitional:\n[] patient to record output for drain, f/u with Dr. ___ ___ 2 \nweeks to determine removal\n[] Follow up drainage cultures to ensure not resistant to \nAugmentin (no sensitivities pending as of ___\n[] Augmentin through ___ for total 7d course from drain \nplacement\n[] Consider restarting ___ services when Mr. ___ returns \nfrom ___ (___)\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Ondansetron 4 mg PO Q8H:PRN nausea  \n2. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild \n3. Apixaban 2.5 mg PO BID \n4. Creon 12 1 CAP PO TID W/MEALS \n5. Pregabalin 100 mg PO QHS \n6. Prochlorperazine 10 mg PO BID: PRN  nausea \n7. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line \n8. Pantoprazole 40 mg PO Q12H \n9. Pyridoxine 100 mg PO DAILY \n10. Multivitamins 1 TAB PO DAILY \n\n \nDischarge Medications:\n1.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H \nRX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by \nmouth every twelve (12) hours Disp #*9 Tablet Refills:*0 \n2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  \n3.  Apixaban 2.5 mg PO BID  \n4.  Creon 12 1 CAP PO TID W/MEALS  \n5.  Docusate Sodium 100 mg PO BID:PRN Constipation - First Line  \n\n6.  Multivitamins 1 TAB PO DAILY  \n7.  Ondansetron 4 mg PO Q8H:PRN nausea   \n8.  Pantoprazole 40 mg PO Q12H  \n9.  Pregabalin 100 mg PO QHS  \n10.  Prochlorperazine 10 mg PO BID: PRN  nausea  \n11.  Pyridoxine 100 mg PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAcute Cholecystitis status post percutaneous cholecystectomy\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr ___, \n\nIt was a pleasure taking care of you here at ___ \n___. \n\nWHY YOU WERE ADMITTED:\nYou were admitted to the hospital with infection of the \ngallbladder. You had a tube placed to drain the infected \nmaterial and will complete a course of antibiotics. \n\nWHAT TO DO WHEN YOU GO HOME:\n- Take your Augmentin twice per day, 12 hours apart (first dose \n___ ___ the evening). The course ends on ___.\n- Follow up with Dr. ___ surgery to make sure you are \nhealing properly. \n- Keep track of how much fluid the drain puts out. If the fluid \noutput ceases or becomes very minimal, it may be time to remove \nthe drain.\n- If you develop fevers, abdominal pain, change ___ the drainage \ncolor or any other symptom that concerns you please call your \noncologist right away. \n\nWe wish you the best! \nYour care team\n \nFollowup Instructions:\n___\n",
  "boolean_questions": {
    "qafib": {
      "criterion": "afib",
      "question": "Does the note describe the patient as having permanent, paroxysmal, or persistent afib?",
      "answer": "No",
      "not_specified": false
    },
    "qprior_stroke": {
      "criterion": "prior_stroke",
      "question": "Does the note describe the patient as ever having a stroke or transient ischemic attack?",
      "answer": "No",
      "not_specified": false
    },
    "qarterial_hypertension": {
      "criterion": "arterial_hypertension",
      "question": "Does the note describe the patient as having arterial hypertension on treatment (high bp e.g. >140, or HTN)?",
      "answer": "No",
      "not_specified": false
    },
    "qt2d": {
      "criterion": "t2d",
      "question": "Does the note describe the patient as having Diabetes mellitus (DM1, DM2, T2D, T1DM, T2DM)?",
      "answer": "Yes",
      "not_specified": false
    },
    "qheart_failure": {
      "criterion": "heart_failure",
      "question": "Does the note describe the patient as having heart failure?",
      "answer": "No",
      "not_specified": false
    },
    "qsurgical_valvular_disease": {
      "criterion": "surgical_valvular_disease",
      "question": "Does the note describe the patient as ever having valvular disease requiring surgery (stenosis)?",
      "answer": "No",
      "not_specified": false
    },
    "qafib_ablation": {
      "criterion": "afib_ablation",
      "question": "Does the note describe the patient as having a planned or past ablation procedure for afib?",
      "answer": "No",
      "not_specified": false
    },
    "qbleeding": {
      "criterion": "bleeding",
      "question": "Does the note describe the patient as having a serious bleeding in the past 6 months?",
      "answer": "Yes",
      "not_specified": false
    },
    "qpeptic_ulcer_disease": {
      "criterion": "peptic_ulcer_disease",
      "question": "Does the note describe the patient as ever having peptic ulcer disease?",
      "answer": "No",
      "not_specified": false
    },
    "qrecent_stroke": {
      "criterion": "recent_stroke",
      "question": "Does the note describe the patient as having a stroke during this admission or within the last month? (Answer yes for any recent stroke if the date is unclear)",
      "answer": "No",
      "not_specified": false
    },
    "qhemorrhagic": {
      "criterion": "hemorrhagic",
      "question": "Does the note describe the patient as ever having any hemorrhagic tendencies or blood dyscrasias?",
      "answer": "Yes",
      "not_specified": false
    },
    "qbipolar": {
      "criterion": "bipolar",
      "question": "Does the note describe the patient as ever being diagnosed with bipolar disorder?",
      "answer": "No",
      "not_specified": false
    },
    "qschizophrenia": {
      "criterion": "schizophrenia",
      "question": "Does the note describe the patient as ever being diagnosed with schizophrenia or any schizoaffective disorders?",
      "answer": "No",
      "not_specified": false
    },
    "qmdd": {
      "criterion": "mdd",
      "question": "Does the note describe the patient as ever being diagnosed with depression or major depressive disorder (MDD)?",
      "answer": "No",
      "not_specified": false
    },
    "qmed_decisions": {
      "criterion": "med_decisions",
      "question": "Does the note describe the patient as being unable to make medical decisions? (Answer no unless there is evidence the patient cannot make their own medical decisions).",
      "answer": "No",
      "not_specified": false
    }
  },
  "numeric_questions": {
    "qchads2": {
      "criterion": "chads2",
      "question": "What is the highest CHADS2 score mentioned? Answer \"NA\" if no CHADS2 score is in the note. ",
      "answer": "",
      "not_specified": false
    },
    "qblood_glucose": {
      "criterion": "blood_glucose",
      "question": "What is the highest blood glucose lab mentioned? Answer \"NA\" if no blood glucose score is in the note.",
      "answer": "100",
      "not_specified": false
    },
    "qlvef": {
      "criterion": "lvef",
      "question": "What is the lowest left ventricular ejection (LVEF, ef, ejection fraction) fraction mentioned in the note? Answer \"NA\" if no LVEF is in the note, Answer 55 if the lowest value is 55% or greater.",
      "answer": "",
      "not_specified": false
    },
    "qPLT": {
      "criterion": "PLT",
      "question": "What is the lowest platelet count (PLT) mentioned in the note? Answer \"NA\" if no platelet count is available in the note.",
      "answer": "",
      "not_specified": false
    },
    "qHGB": {
      "criterion": "HGB",
      "question": "What is the lowest hemoglobin (HGB) mentioned in the note? Answer \"NA\" if no HGB value is available in the note.",
      "answer": "8.1",
      "not_specified": false
    },
    "qCREAT": {
      "criterion": "CREAT",
      "question": "What is the higest serum creatinine (Creat) mentioned in the note? Answer \"NA\" if no creatinine value is available in the note.",
      "answer": "0.7",
      "not_specified": false
    },
    "qAST": {
      "criterion": "AST",
      "question": "What is the higest aspartate aminotransferase level (AST) mentioned in the note? Answer \"NA\" if no AST value is available in the note.",
      "answer": "15",
      "not_specified": false
    },
    "qBILI": {
      "criterion": "BILI",
      "question": "What is the higest total bilirubin (TotBili, Bili) mentioned in the note? Answer \"NA\" if no bilirubin value is available in the note.",
      "answer": "0.8",
      "not_specified": false
    }
  },
  "patient_number": 41
}